NCT01827293View on ClinicalTrials.gov

Promethazine vs. Lorazepam for Treatment of Vertigo

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Peripheral Vertigo.
Interventions
DRUG

Promethazine

DRUG

Lorazepam

Trial Locations (1)

17666-33815

Department of Neurology, Emam Hossein Hospital, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT01827293 - Promethazine vs. Lorazepam for Treatment of Vertigo | Biotech Hunter | Biotech Hunter